Unique mulberry extract for blood sugar management
Lead Participant:
PHYNOVA GROUP LIMITED
Abstract
The project combines the expertise of 4 UK partners to characterise, formulate & develop a UK supply chain for IminoNorm™, a proprietary natural ingredient that, when incorporated into foods & beverages, can address diet-related health conditions such as diabetes and obesity. IminoNorm™ is derived from mulberry leaves which have a strong traditional history of use, particularly in South East Asia (SEA), for blood sugar management. The project will enable the partners to capture a greater share of the product’s value chain, increase UK R&D investment & open up global commercial markets.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| PHYNOVA GROUP LIMITED | £393,346 | £ 236,008 |
Participant |
||
| PHYTOQUEST LIMITED | £40,387 | £ 24,232 |
| INNOVATE UK | ||
| AVRIL BIOPHARMA, INC. | ||
| UNIVERSITY OF SOUTHAMPTON | £61,993 | £ 61,993 |
| NEEM BIOTECH LTD | £95,141 | £ 57,000 |
People |
ORCID iD |
| Alice Lyon (Project Manager) |